Canopy Growth (CGC) Exchange Rate Effect (2019 - 2026)
Canopy Growth (CGC) posted Exchange Rate Effect of -$4.8 million for Q4 2025, up 16.11% sequentially from -$5.8 million in Q2 2025, and down 226.58% YoY from $3.8 million in Q4 2024.
Canopy Growth (CGC) Exchange Rate Effect (2019 - 2026) Analysis & Trends
Canopy Growth has reported Exchange Rate Effect for 7 years, with the latest figure at -$4.8 million in Q4 2025.
- Quarterly Exchange Rate Effect fell 226.58% year-over-year to -$4.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$6.7 million (down 215.28% YoY) and the FY2026 annual result came in at -$3.5 million, down 128.04% from the prior year.
- Exchange Rate Effect improved to -$4.8 million in Q4 2025 per CGC's latest filing, from -$5.8 million in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $27.9 million in Q3 2022 and troughed at -$12.0 million in Q1 2022.
- A 5-year average of $171247.1 and a median of -$201976.3 in 2024 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect soared 732.99% in 2024, then tumbled 988.39% in 2025.
- Over 5 years, Exchange Rate Effect stood at -$502181.7 in 2021, then sank by 825.83% to -$4.6 million in 2022, then surged by 86.98% to -$605257.3 in 2023, then surged by 732.99% to $3.8 million in 2024, then tumbled by 226.58% to -$4.8 million in 2025.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$4.8 million, -$5.8 million, and $3.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Canopy Growth | 445.49 Mn | 198.48 Mn | 16.08 Mn | 3.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.73 Mn |
| Jun 30, 2026 | 3.73 Mn |
| Dec 31, 2025 | -4.85 Mn |
| Dec 31, 2025 | -4.85 Mn |
| Jun 30, 2025 | -5.78 Mn |
| Jun 30, 2025 | -5.78 Mn |
| Dec 31, 2024 | 3.83 Mn |
| Dec 31, 2024 | 3.83 Mn |
| Sep 30, 2024 | 98,229.16 |
| Sep 30, 2024 | 98,229.16 |
| Jun 30, 2024 | 650,715.09 |
| Jun 30, 2024 | 650,715.09 |
| Mar 31, 2024 | 1.23 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | -605,257.27 |
| Dec 31, 2023 | -605,257.27 |
| Sep 30, 2023 | 1.79 Mn |
| Sep 30, 2023 | 1.79 Mn |
| Jun 30, 2023 | -3.38 Mn |
| Jun 30, 2023 | -3.38 Mn |